Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03056105
Other study ID # 230734
Secondary ID
Status Completed
Phase N/A
First received February 10, 2017
Last updated May 24, 2017
Start date February 3, 2013
Est. completion date February 4, 2014

Study information

Verified date May 2017
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study was to examine how participation in a 1 month intensive Insight (vipassana) Meditation retreat (a) affects biological markers of cellular aging, social affiliation, and inflammation, which are important for physical health, longevity, and behavior, and (b) to relate observed biological changes to baseline levels and changes in psychological traits, which may underlie improvements in personal adaptive functioning.


Description:

The investigators are specifically assessing the effects of retreat on telomere length and telomerase levels in participants' white blood cells, as well as plasma levels of interlukin-6 (IL-6), to assess how the retreat experience impacts these markers of cellular aging and inflammation. The hypotheses are that retreat participation will increase both telomere length and telomerase activity, but decrease IL-6 levels. The investigators will also assess the impact of retreat participation on oxytocin—a hormone involved in a number of physiological and behavioral processes, including affiliative bonds and stress responses—the hypothesis being that participation in the retreat will increase plasma oxytocin levels. The investigators will then explore how these and other biomarkers relate to psychological processes and personality traits, which may also be altered by participation in the meditation retreat.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date February 4, 2014
Est. primary completion date February 4, 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Previous meditation experience equivalent to two 5-10 day residential meditation retreats

Exclusion Criteria:

- Disclosure of potentially contagious blood-borne illness (e.g., HIV, Hepatitis, etc.) or other illnesses that might interfere with telomere or telomerase measurement

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Residential Insight Meditation Retreat
Retreats at Spirit Rock Meditation Center were led by teams of 6 experienced teachers. Participants practiced "noble silence"—refraining from eye contact as well as verbal and written communication—except during meetings with teachers. Teachers lead guided Insight meditation practices, as well as meditations on loving-kindness, compassion, empathetic joy, and equanimity. The daily schedule consisted of sitting and walking meditation sessions (30-45 mins) totaling 8-10 hours/day, meals, and short work meditations (sweeping, dishes, etc.). Seated meditation was practiced as a group in a meditation hall with approximately 80 participants. Walking meditation took place in adjoining halls or on the grounds. Participants lived on-site during the retreat and were provided with a vegetarian diet.

Locations

Country Name City State
United States University of California, Davis Davis California

Sponsors (3)

Lead Sponsor Collaborator
University of California, Davis University of Barcelona, University of California, San Francisco

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Gene Expression of genes relating to inflammation and telomere regulation PBMC RNA for exploratory gene expression studies two measurements, three weeks
Primary Telomerase an enzyme that repairs the shortening of telomeres that occurs during aging change from the start of retreat to three weeks into the retreat period
Primary Telomere length the repetitive sequence of DNA that serves as a protective cap to eukaryotic chromosomes, which protects from degradation and instability and is related to longevity change from the start of retreat to three weeks into the retreat period
Primary Interleukin-6 a primary measure of inflammation, which is influenced by psychological stress change from the start of retreat to three weeks into the retreat period
Primary Oxytocin an affiliative hormone associated with social bonding in both men and women, and which downregulates inflammatory cytokines change from the start of retreat to three weeks into the retreat period
Secondary Arginine Vasopressin a less commonly studied affiliative hormone also associated with close social bonds two measurements, three weeks apart
Secondary Brain Derived Neurotrophic Factor a protein related to neuroplasticity, learning, and memory, which is decreased in depression two measurements, three weeks apart
Secondary pro- and anti-inflammatory cytokines (IL-1b, IL-2, IL-4, IL-5, IL-10, IL-12 (p70), IL-13, IFN-?, TNF-a) a family of proteins involved in generating and regulating the immune system two measurements, three weeks apart
Secondary State-Trait Anxiety Inventory 10 item scale designed to assess trait-anxiety (STAI; Spielberger et al., 1983) two measurements, three weeks apart
Secondary Lifestyle Profile II Assesses health-promoting lifestyle factors (Walker et al., 1987) two measurements, three weeks apart
Secondary Experience in Close Relationships, short form Assesses attachment anxiety (fear of rejection or abandonment) and avoidance (avoidance of intimacy and interdependence) (ECR-12: Lafontaine et al., 2015) two measurements, three weeks apart
Secondary Mysticism Scale Assesses mystical experience and religious interpretation (M-Scale; Hood, 1975) two measurements, three weeks apart
Secondary Non-attachment Scale Assesses non-attachment from a Buddhist perspective (NAS; Sahdra, Shaver & Brown, 2010) two measurements, three weeks apart
Secondary Self-Assessed Wisdom Scale Assess five dimensions of wisdom: 1) Experience, 2) Emotional Regulation, 3) Reminiscence and Reflectiveness, 4) Openness, 5) Humor (SAWS; Webster, 2003) two measurements, three weeks apart
Secondary Ego Resiliency Scale Assesses the ability to adapt one's level of control temporarily up or down as circumstances dictate (EGO; Block & Kremen, 1996) two measurements, three weeks apart
Secondary Five Facet Mindfulness Questionnaire Assesses five facets of mindfulness: 1) Non-reactivity to Inner Experience, 2) Observing 3) Acting with Awareness, 4) Describing, and 5) Non-judging of Experience (FFMQ; Baer et al., 2006) two measurements, three weeks apart
Secondary Center for Epidemiological Studies Depression Scale Assesses depressive symptomatology (CES-D; Radloff, 1977) two measurements, three weeks apart
Secondary Psychological Wellbeing Scale Assess autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance (PWBS; Ryff, 1989) two measurements, three weeks apart
Secondary Three Dimensional Wisdom Scale Assess three dimensions of wisdom: 1) Cognitive, 2) Reflective, and 3) Affective (3-DWS; Ardelt, 2003) two measurements, three weeks
Secondary Big Five Inventory Assesses extraversion, agreeableness, conscientiousness, openness to experience, neuroticism (BFI; Goldberg, 1993) two measurements, three weeks
Secondary Difficulties in Emotion Regulation Scale Assesses non-acceptance to one's emotional responses, difficulty achieving goals, impulsiveness, lack of emotional awareness, access to emotion regulation strategies, emotional clarity (DERS; Gratz & Roemer, 2004) two measurements, three weeks
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A